Abbott Laboratories

(ABT) - Get Report

plans to provide Africa with HIV medications and tests at heavily discounted prices, following in the footsteps of other large drug companies.

Abbott, a pharmaceutical company based in Abbott Park, Ill., will offer Kaletra and Norvir, both antiretroviral medications used to treat HIV, and its Determine HIV-1/2 test. The drugs and the tests will be available to government and nongovernmental organizations, United Nations system organizations and other national and international health institutions. The company won't record any profits from the agreement.

TST Recommends

Earlier this year,

Merck

(MRK) - Get Report

said it would

cut the prices of two drugs used to treat patients with HIV in Africa and other developing areas.

GlaxoSmithKline

(GSK) - Get Report

also announced plans to expand its program of offering lower-priced HIV and AIDS drugs in developing countries.

Shares of Abbott gained 30 cents, or 0.7%, to $44.55 in recent

New York Stock Exchange

trading.